Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19

Mostrar otras versiones (1)

BACKGROUND: The high heterogeneity in the symptoms and severity of COVID-19 makes it challenging to identify high-risk patients early in the disease. Cardiometabolic comorbidities have shown strong associations with COVID-19 severity in epidemiologic studies. Cardiometabolic protein biomarkers, ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Schroeder, Philip H., Brenner, Laura N., Kaur, Varinderpal, Cromer, Sara J., Armstrong, Katrina, LaRocque, Regina C., Ryan, Edward T., Meigs, James B., Florez, Jose C., Charles, Richelle C., Mercader, Josep M., Leong, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301894/
https://www.ncbi.nlm.nih.gov/pubmed/35864532
http://dx.doi.org/10.1186/s12933-022-01569-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301894/
https://www.ncbi.nlm.nih.gov/pubmed/35864532
http://dx.doi.org/10.1186/s12933-022-01569-7

Ejemplares similares